About Us

Coulter Partners is a global search specialist focused exclusively on life sciences. The firm is held in the highest regard as trusted adviser to the sector on senior leadership roles in the American, U.K. and European Markets.

They have a combined expertise gained over 25 years in the industry, concentrated in the largest dedicated Life Sciences team in North America and Europe. 75 consultants work together as a single global P&L from 10 offices; 5 of these are in the US and 5 in Europe.

The firm’s approach is to hire and develop exceptional multi-skilled sector analysts with PhDs, MBAs, deep industry knowledge and an outstanding track record of search at Executive and Board level. Its team culture and personal reward system are founded on commitment to the highest standards of client and candidate service.

Their mission is to impact the industry’s ability to deliver advances in diagnosis, prevention, treatment and management of disease. They do this by bringing the world’s best talent to a broad spectrum of global clients; from multinationals, to small and midcap businesses, as well as to the global investor community, building their own teams and the boards and executive leadership of their portfolio investments.

Find a Recruiter

17

At the heart of everything they do Coulter Partners is an exceptional team of talented individuals. Multi-disciplined, passionate and committed to being the best, they have PhDs, MBAs and speak many languages. Every challenge is approached with a blend of innovative thinking and best-in-class search methodology. There are no barriers to sharing information and everyone is rewarded for quality delivery. Exchanging knowledge, experience and data brings mutual support. Success follows naturally.

Solutions And Expertise

Coulter Partners is a global search specialist focused exclusively on life sciences. The firm is held in the highest regard as trusted adviser to the sector on senior leadership roles in the American, U.K. and European Markets.

Solutions
  • Executive Search
Industries
Functions
  • CEO/President
  • Finance/Accounting
  • Human Resources
  • Marketing & Sales

News Briefings

Coulter Partners Lands CEO for Ovizio Imaging Systems

Global executive search firm Coulter Partners has placed Emilie Viey as the new CEO of Ovizio Imaging Systems, a life science imaging technology company. Philip Mathuis, who co-founded Ovizio, recently stepped down. Philipp Buis, Coulter’s executive director, led the assignment. Dr. Viey will lead Ovizio’s further development as solution provider for imaging applications in life sciences.

Coulter Partners Continues Global Expansion

Global executive search firm Coulter Partners recently made eight new appointments in the U.S., Denmark and at their London headquarters. In the U.S., Noah Parekh joins as client partner in Cambridge, MA, while Lisa Pieper has been appointed consulting partner in Palo Alto, CA, and Adrienne Slutzky joins as project coordinator in Short Hills, NJ. In London,

Coulter Partners Opens New Office in Pittsburgh
 Coulter Partners Pittsburgh Rachel Matos Rebecca Russell

Global executive search firm Coulter Partners recently opened a new office in Pittsburgh and brought in research analysts Rachel Matos and Rebecca Russell to work at that location. Coulter Partners’ London headquarters, meanwhile, consolidated its research analyst capability with the appointment of Matthew Dennehy. “We are delighted to be investing in new technologies and skills both in

Coulter Partners Lands CEO for George Health Technologies

Executive search firm Coulter Partners has placed Phil Offer as the new CEO of George Health Technologies. Based in Sydney, Australia, his primary focus will be to develop the company’s business growth strategy and commercial opportunities. “This was a truly global search for a truly global role and we developed multiple candidate relationships, in multiple time zones,”

Press Releases

Coulter Partners secures Chief Medical Officer for Proclara Biosciences

CAMBRIDGE, MA, January 3, 2018 – Coulter Partners was delighted to partner with Proclara Biosciences to help strengthen their leadership team with the appointment of David Michelson, M.D., as Chief Medical Officer. Proclara is a biotechnology company developing novel therapies for diseases caused by protein misfolding. Dr. Michelson joins Proclara from Merck Research Laboratories, where he served

Coulter Partners secures CEO for Stevenage Bioscience Catalyst

LONDON, UK, January 8, 2018 – Coulter Partners was pleased to partner with Stevenage Bioscience Catalyst, to help secure the appointment of Dr Sally Ann Forsyth as Chief Executive Officer. Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve healthcare, has announced that Dr Forsyth will join as CEO in March 2018. She

Coulter Partners Strengthens Global Team With Further Appointments in London

LONDON, U.K., September 20, 2017 — Life Sciences search specialist, Coulter Partners is pleased to announce four new appointments at their London headquarters to consolidate team capabilities globally. Mark Sharp returns to Coulter Partners as Associate Director and Dr Evgenia Galinskaya joins as Production Associate, while Sam Kirby and Dr Sara Gordon are appointed Research Associates.

Coulter Partners Consolidates Global Team

LONDON, U.K., June 22, 2017 — Coulter Partners consolidates global team with appointments in Los Angeles, Orange County, New York, Boston, Zurich, Frankfurt and London. Global Life Sciences search specialist, Coulter Partners is pleased to announce seven new appointments in the US, Switzerland, Germany and at their London headquarters, following an extremely successful year which has seen

Coulter Partners places Head of Research for Summit Therapeutics.

LONDON, UK, June, 7, 2017 – Coulter Partners was pleased to partner with Summit Therapeutics to secure the appointment of Dr Dave Powell as Head of Research. Summit is a biopharmaceutical company focused on discovery and development to advance therapies for Duchenne muscular dystrophy (‘DMD’) and Clostridium difficile infection (‘CDI’). The company has recently announced a

Do NOT follow this link or you will be banned from the site!